Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation
about
sameAs
Positive correlations of age and parity with plasma concentration of macrophage migration inhibitory factor in Japanese black cowsCurrent status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation.Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection.Gene expression of purified beta-cell tissue obtained from human pancreas with laser capture microdissection.Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation.Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters.Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice.Combined strategy of endothelial cells coating, Sertoli cells coculture and infusion improves vascularization and rejection protection of islet graftPreparatory studies of composite mesenchymal stem cell islets for application in intraportal islet transplantation.Pancreatic islet xenograft survival in mice is extended by a combination of alpha-1-antitrypsin and single-dose anti-CD4/CD8 therapy.β-Cell inflammation in human type 2 diabetes and the role of autophagy.Responses of IL-18- and IL-18 receptor-deficient pancreatic islets with convergence of positive and negative signals for the IL-18 receptorTransplantation of heterospheroids of islet cells and mesenchymal stem cells for effective angiogenesis and antiapoptosis.Pro-inflammatory and pro-oxidant status of pancreatic islet in vitro is controlled by TLR-4 and HO-1 pathways.Portal vein thrombosis is a potentially preventable complication in clinical islet transplantationMacroporous three-dimensional PDMS scaffolds for extrahepatic islet transplantation.Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus.Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets.Treatment with Tacrolimus and Sirolimus Reveals No Additional Adverse Effects on Human Islets In Vitro Compared to Each Drug Alone but They Are Reduced by Adding Glucocorticoids.Chemokines and their receptors in islet allograft rejection and as targets for tolerance induction.alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in miceInduction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets.Allogeneic islet transplantation.Challenges and emerging technologies in the immunoisolation of cells and tissues.Current advances and travails in islet transplantation.Manufacturing porcine islets: culture at 22 °C has no advantage above culture at 37 °C: a gene expression evaluationThrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics.Advances in thymosin beta10 research: differential expression, molecular mechanisms, and clinical implications in cancer and other conditions.Immunological aspects of pancreatic islet cell transplantation.Immune monitoring of pancreatic islet graft: towards a better understanding, detection and treatment of harmful events.Alternative transplantation sites for pancreatic islet grafts.Toward engineering a novel transplantation site for human pancreatic islets.APT070 (mirococept), a membrane-localizing C3 convertase inhibitor, attenuates early human islet allograft damage in vitro and in vivo in a humanized mouse model.Progress and challenges in macroencapsulation approaches for type 1 diabetes (T1D) treatment: Cells, biomaterials, and devices.Islet inflammation in type 2 diabetes.Intraportal islet transplantation: the impact of the liver microenvironment.Cell-Permeable Peptide Blocks TLR4 Signaling and Improves Islet Allograft Survival.Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetesAn IFIH1 gene polymorphism associated with risk for autoimmunity regulates canonical antiviral defence pathways in Coxsackievirus infected human pancreatic islets.
P2860
Q28597422-FFC514EE-30EF-4134-9FFC-85FA8ED62868Q30430008-13207AB0-D36C-4A13-8F1A-B1F2BC979928Q30437086-2361519F-1FF3-4B75-94B1-89838BF5029EQ30450509-39CD23C4-C429-4C6C-A75F-5C57B0474D9AQ33309763-C60C2E39-BD19-4AB7-9C49-4C0AC0B86153Q33355903-357E32D3-3DCB-4433-8D6C-2045D54DC956Q33598329-5B620409-90B3-4309-B2E2-65F27D983A1BQ33922982-99E94989-BC00-49F3-9594-062F1FEEA06EQ34329542-9C3ED20D-C7B8-416E-97A4-F522B0674DE4Q34577332-5F8C63A5-45AA-4482-92E6-5DC1CEFCD56EQ34744307-537ADB27-0E24-4219-8B7F-1E5636C144F3Q34977998-670C6E37-26C4-471A-ADDF-087A1F431F8EQ35130769-56F9A4DF-7312-4378-B23A-FB83AD1866B4Q35167245-450F510C-FE7D-416E-A79F-7CE61FC0433CQ35364286-0DDBEA80-BC14-4A89-9BE6-D8FE429B275FQ35581203-D15AD06D-1395-4292-BC02-D34B21377B96Q35601055-1212E3A3-AF7A-412F-85FC-E5BF26CA34BBQ35910576-44FE16D4-841E-4AFD-B1DD-EE8EEB21C0BCQ36458495-62A84A79-625D-4292-85C6-D36F2D3CC4E6Q36538911-1E6EA63E-C9AB-494B-B331-77445D6BAA36Q36560836-F96951C3-F3EA-41DA-870C-5EAAF4D710ABQ36935759-0ADF5CB2-D1EE-473B-838F-6423A73BFEB1Q36978822-5E38B526-74A4-4C09-A492-7EAFE5716740Q36981652-23AA8FBC-A148-4250-AB9B-27A15136C3B7Q37006047-7ED31752-E52A-4972-BA15-9D16A4794F4FQ37360411-E4325386-2B6A-4093-8595-A61B4DD27510Q37360876-C0016965-2565-42E0-A284-6D4BFE538F6AQ37404257-2714BA76-A1F4-49D3-8C5B-142DFBC03C4DQ37631585-025CF30F-C014-4CBB-A4A7-964A709771F3Q37729050-6F3BD848-BF9A-4558-BE5A-DA18D51AB171Q37809052-F2B8A9FF-9A34-44BA-8B3B-8756F370C7B5Q37905693-9636839C-4827-4E98-B7C3-25C69AE0B650Q38101322-052795E0-35C6-45EE-B16F-9377B5D963FAQ38411332-591D0C1C-2FE0-4431-8855-B7E589A43FB4Q38651610-C1B26FA9-9DDA-4E0A-A672-24F680706022Q38740642-1512F706-84D3-49FB-BE0F-24C1ED1AFB79Q38767617-E8FAD06F-3B95-4E5A-B398-60A432C4EF68Q38803353-5C089AF7-F402-4E41-A744-B505DFF6B667Q38888130-DD67D909-E223-4137-BF53-50087F42E82FQ39613796-2BF7FB9F-A0D5-436A-9CE7-070832EC75AB
P2860
Inflammatory mediators expressed in human islets of Langerhans: implications for islet transplantation
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Inflammatory mediators express ...... ions for islet transplantation
@ast
Inflammatory mediators express ...... ions for islet transplantation
@en
Inflammatory mediators express ...... ions for islet transplantation
@nl
type
label
Inflammatory mediators express ...... ions for islet transplantation
@ast
Inflammatory mediators express ...... ions for islet transplantation
@en
Inflammatory mediators express ...... ions for islet transplantation
@nl
prefLabel
Inflammatory mediators express ...... ions for islet transplantation
@ast
Inflammatory mediators express ...... ions for islet transplantation
@en
Inflammatory mediators express ...... ions for islet transplantation
@nl
P50
P3181
P1476
Inflammatory mediators express ...... ions for islet transplantation
@en
P2093
Annika Olsson
Ulrika Johansson
P304
P3181
P356
10.1016/S0006-291X(03)01392-5
P407
P577
2003-08-01T00:00:00Z